These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Results of follow-up on advanced cases of pulmonary tuberculosis converted to negative with rifampicin treatment]. Yamamoto M, Isoe K, Nakamura H, Hirose H, Izumi S. Kekkaku; 1972 Nov; 47(11):393-7. PubMed ID: 4630902 [No Abstract] [Full Text] [Related]
4. [Short course chemotherapy for pulmonary tuberculosis with duration for 6 months after sputum negative conversion. (Report 1)--Report of the 19--20th A series of controlled trial of chemotherapy--(author's transl)]. Kekkaku; 1979 Jan; 54(1):51-61. PubMed ID: 107362 [No Abstract] [Full Text] [Related]
5. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance]. Baba H, Takahashi R, Azuma Y. Kekkaku; 1971 Nov; 46(11):429-35. PubMed ID: 5004056 [No Abstract] [Full Text] [Related]
7. [A long-term observation on previously treated cases of pulmonary tuberculosis retreated with rifampicin for more than six months (author's transl)]. Tamura M, Takazawa N, Asada T, Ikegaki H, Yamada M, Kushiro S, Tada T. Kekkaku; 1979 May; 54(5):285-95. PubMed ID: 113607 [No Abstract] [Full Text] [Related]
8. [Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)]. Kameda K, Okamura S, Yamamoto S, Iwai K. Kekkaku; 1975 Jul; 50(7):185-9. PubMed ID: 810614 [No Abstract] [Full Text] [Related]
9. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis. Gyselen A. Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555 [No Abstract] [Full Text] [Related]
10. [Effect of rifampicin on the L transformation of a mycobacterial population in patients with destructive pulmonary tuberculosis]. Karachunskiĭ MA, Dorozhkova IR, Chukanov VI, Balta IuE, Kiazimova LM. Probl Tuberk; 1986 Jun; (9):31-4. PubMed ID: 3097632 [No Abstract] [Full Text] [Related]
14. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S. East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [Abstract] [Full Text] [Related]
15. [The smear-positive and culture-negative phenomenon of mycobacteria in sputum specimens in relation to the problems on the detection of mycobacteria (author's transl)]. Kudoh S. Kekkaku; 1981 Jun; 56(6):291-9. PubMed ID: 6795379 [No Abstract] [Full Text] [Related]
18. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)]. Urakami E, Nagasawa S. Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413 [No Abstract] [Full Text] [Related]
19. [Changes in the indication of surgical treatment for pulmonary tuberculosis in accordance with the introduction of rifampicin based on bacteriological findings on culture of resected specimens (author's transl)]. Kekkaku; 1977 Jul; 52(7):353-60. PubMed ID: 409871 [No Abstract] [Full Text] [Related]